Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens-Reference-Cited by-同舟云学术

Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens

Published:2008-01 Issue:1-2 Volume:329 Page:138-150
ISSN:0022-1759
Container-title:Journal of Immunological Methods
language:en
Short-container-title:Journal of Immunological Methods

Author:

Saerens Dirk,Stijlemans Benoît,Baral Toya Nath,Nguyen Thi Giang Thanh,Wernery Ulrich,Magez Stefan,De Baetselier Patrick,Muyldermans Serge,Conrath Katja

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies;Arbabi Ghahroudi;FEBS Lett.,1997

2. Phage display technology: clinical applications and recent innovations;Azzazy;Clin. Biochem.,2002

3. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor;Baral;Nat. Med.,2006

4. Advances in functional protein microarray technology;Bertone;Febs. J.,2005

5. African trypanosomiasis: changing epidemiology and consequences;Chretien;Curr. Infect. Dis. Rep.,2005

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of nanobody applications in diagnosis and detection;MedComm – Biomaterials and Applications;2023-09

2. Nanobodies: COVID-19 and Future Perspectives;Frontiers in Drug Discovery;2022-07-18

3. Characterization of rabbit polyclonal antibody against camel recombinant nanobodies;Open Life Sciences;2022-01-01

4. A comprehensive comparison between camelid nanobodies and single chain variable fragments;Biomarker Research;2021-12

5. Application of Single-Domain Antibodies (“Nanobodies”) to Laboratory Diagnosis;Annals of Laboratory Medicine;2021-11-01